Clincosm LogoSign in Get a demo

Polycythemia Vera

Showing 1 - 25 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera Trial in Italy

Recruiting
  • Polycythemia Vera
    • Reggio Calabria, Calabria, Italy
    • +21 more
    Nov 10, 2023

    Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

    Not yet recruiting
    • Polycythemia Vera
    • Givinostat Hydrochloride
    • Hydroxy Urea
    • (no location specified)
    Oct 19, 2023

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    Polycythemia Vera Trial (Open-label rusfertide)

    Not yet recruiting
    • Polycythemia Vera
    • Open-label rusfertide
    • (no location specified)
    Sep 5, 2023

    Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

    Recruiting
    • Polycythemia Vera
      • Sohag, Egypt
        Faculty of Medicine
      Aug 12, 2023

      Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

      Recruiting
      • Myeloproliferative Neoplasm
      • +7 more
        • Hong Kong, Hong Kong
          Department of Medicine, Queen Mary Hospital
        May 21, 2023

        Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

        Recruiting
        • Polycythemia Vera
        • Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        May 19, 2023

        A Prospective, Non-interventional Study of JAKAVI® Treatment in

        Active, not recruiting
        • Polycythemia Vera
        • Jakavi
        • Reutlingen, Baden Wuerttemberg, Germany
        • +98 more
        May 16, 2023

        Polycythemia Vera Trial (Hydroxyurea)

        Not yet recruiting
        • Polycythemia Vera
        • (no location specified)
        May 2, 2023

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +9 more
        • Los Angeles, California
        • +5 more
        Jan 27, 2023

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +36 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Jan 23, 2023

        Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

        Active, not recruiting
        • Polycythemia Vera
        • San Giovanni Rotondo, (FG) Puglia, Italy
        • +22 more
        Jan 10, 2023

        Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

        Active, not recruiting
        • Myeloproliferative Neoplasm
        • +4 more
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Jan 6, 2023

        Polycythemia Vera Trial in Hirakata, Izumo, Osaka (PPMX-T003)

        Recruiting
        • Polycythemia Vera
        • Hirakata, Osaka, Japan
        • +2 more
        Nov 14, 2022

        Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

        Completed
        Has Results
        • Myelodysplastic Syndrome
        • +13 more
        • Baltimore, Maryland
          Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
        Nov 2, 2022

        Identify and Describe Predictive Factors for Thromboembolic

        Not yet recruiting
        • Polycythemia Vera
        • Hydroxyurea
        • Ruxolitinib
        • (no location specified)
        Nov 2, 2022

        Polycythemia Vera Trial (bomedemstat)

        Not yet recruiting
        • Polycythemia Vera
        • (no location specified)
        Oct 24, 2022

        QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine

        Not yet recruiting
        • Polycythemia Vera
        • (no location specified)
        Sep 30, 2022

        Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

        Active, not recruiting
        • Myelofibrosis
        • +2 more
        • New Orleans, Louisiana
        • +20 more
        Aug 25, 2022

        Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

        Recruiting
        • Acute Myeloid Leukemia
        • +8 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Aug 18, 2022

        Polycythemia Vera Trial (SLN124, Placebo)

        Not yet recruiting
        • Polycythemia Vera
        • (no location specified)
        Aug 10, 2022

        Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

        Active, not recruiting
        • Polycythemia Vera
        • Ropeginterferon alfa-2b
        • Beijing, China
        • +13 more
        Aug 1, 2022

        Polycythemia Vera Trial in Worldwide (Placebo, Rusfertide)

        Recruiting
        • Polycythemia Vera
        • Fresno, California
        • +34 more
        Jul 28, 2022

        Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

        Not yet recruiting
        • Polycythemia Vera
        • Ropeginterferon alfa-2b-njft (P1101)
        • (no location specified)
        Jul 28, 2022

        Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

        Terminated
        • Essential Thrombocythemia
        • +2 more
        • Arsenic Trioxide
        • +3 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Jul 20, 2022